Radiosensitivity Of Prostate Cancer Cells Research Articles

1390 POSTER Selenium radiosensitizes prostate cancer cells in vitro: a beneficial adjunct to radiotherapy?

Survival curves were obtained for haploid and diploid yeasts, Saccharmyces cerevisiae, of wild-type strains and radiosensitive mutants exposed to γ-rays and α-particles. A correlation between the values of the relative biological effectiveness (RBE) of high-LET radiation and cell-repair capacity was found. The difference in radiosensitivities of the wild-type diploid strain and homozygous rad mutants incapable of recovery was significantly higher after low-LET radiation than after high-LET radiation. Possible reasons for the observed radiation responses to low- and high-LET exposure of yeast cells with various genotype are discussed.

CPA7, a Novel Stat3 Inhibitor Radiosensitizes Prostate Cancer Cells

CPA7, a Novel Stat3 Inhibitor Radiosensitizes Prostate Cancer Cells

Preferential radiosensitization of prostate cancer cells by proteasome inhibition

Preferential radiosensitization of prostate cancer cells by proteasome inhibition

The transcriptional inhibition of DNA repair protein Rad51 enhances radiosensitivity in prostate cancer cells

The transcriptional inhibition of DNA repair protein Rad51 enhances radiosensitivity in prostate cancer cells

The transcriptional inhibition of DNA repair protein Rad51 enhances radiosensitivity in prostate cancer cells

The transcriptional inhibition of DNA repair protein Rad51 enhances radiosensitivity in prostate cancer cells